arrow_back Trending Legislation
Share share

Research on Menstrual and Intimate Care Product Safety

This new act aims to research whether popular menstrual and intimate care products contain harmful substances like dioxins or phthalates. These studies will help assess health risks for users, including impacts on fertility and child development, potentially leading to safer products on the market.
Key points
Research will be conducted on the presence of potentially harmful substances (e.g., dioxins, phthalates, fragrances) in tampons, pads, menstrual cups, as well as intimate washes, wipes, and powders.
The research aims to assess health risks, including the risk of diseases (e.g., cancers, fertility issues, infections) and the impact on children's health if mothers used these products during pregnancy.
The act seeks to enhance the safety of everyday products and provide citizens with reliable information about their composition and potential health effects.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2023
Print number: HR 5957
Sponsor: Rep. Meng, Grace [D-NY-6]
Process start date: 2023-10-25
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Research on Menstrual and Intimate Care Product Safety

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 5957.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-10-25.

What are the main provisions?

Key points include:

  • Research will be conducted on the presence of potentially harmful substances (e.g., dioxins, phthalates, fragrances) in tampons, pads, menstrual cups, as well as intimate washes, wipes, and powders.
  • The research aims to assess health risks, including the risk of diseases (e.g., cancers, fertility issues, infections) and the impact on children's health if mothers used these products during pregnancy.
  • The act seeks to enhance the safety of everyday products and provide citizens with reliable information about their composition and potential health effects.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Meng, Grace [D-NY-6].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 5957

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health